Related Experiment Video
Updated: May 2, 2026
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2
Abstract:
The outbreak of 2019 coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic. Despite intensive research including several clinical trials, currently there are no completely safe or effective therapeutics to cure the disease. Here we report a strategy incorporating neutralizing antibodies conjugated on the surface of a photothermal nanoparticle to actively capture and inactivate SARS-CoV-2. The photothermal nanoparticle is comprised of a semiconducting polymer core and a biocompatible polyethylene glycol surface decorated with neutralizing antibodies. Such nanoparticles displayed efficient capture of SARS-CoV-2 pseudoviruses, excellent photothermal effect, and complete inhibition of viral entry into ACE2-expressing host cells via simultaneous blocking and inactivating of the virus. This photothermal nanoparticle is a flexible platform that can be readily adapted to other SARS-CoV-2 antibodies and extended to novel therapeutic proteins, thus providing a broad range of protection against multiple strains of SARS-CoV-2.
Insights
Researchers developed a novel photothermal nanoparticle therapy to capture and inactivate SARS-CoV-2, the virus causing COVID-19. This innovative approach offers a flexible platform for developing broad-spectrum antiviral treatments against multiple coronavirus strains.
Area of Science:
- Nanotechnology
- Virology
- Biomedical Engineering
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, urgently requires effective therapeutic interventions.
- Current treatments for COVID-19 lack complete safety and efficacy.
- Developing novel strategies to neutralize and eliminate SARS-CoV-2 is critical.
Conclusions:
- Antibody-conjugated photothermal nanoparticles represent a promising strategy for combating SARS-CoV-2.
- This technology offers a flexible and adaptable platform for developing next-generation antiviral therapies.
- The approach holds potential for broad protection against diverse SARS-CoV-2 strains and future viral threats.
More Related Videos
Related Concept Videos
01:26Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...